The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.
Ontology highlight
ABSTRACT: Allergic rhinitis (AR) poses a global health problem and can be challenging to treat. Many of the current symptomatic treatments for AR have been available for decades, yet there has been little improvement in patient quality of life or symptom burden over the years. In this review, we ask why this might be and explore the pathophysiological gaps that exist within the various AR treatment classes. We focus on the benefits and drawbacks of different treatment options and delivery routes for AR treatments and consider how, given what is known about AR pathophysiology and symptomatology, patients may be offered more effective treatment options for rapid, effective, and sustained AR control. In particular, we consider how a new AR preparation, MP-AzeFlu (Dymista®, Meda, Sweden), com
SUBMITTER: Bjermer L
PROVIDER: S-EPMC6469109 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA